AGE-RELATED MONOCLONAL GAMMOPATHIES - CLINICAL LESSONS FROM THE AGING C57BL MOUSE

In this article the long-held notion that benign monoclonal gammapathy (BMG) is a premalignant stage in the development of multiple myeloma (MM) is attacked. Jiri Radl argues that clinical and experimental observations indicate that they are separate entities which may be distinguished in the laboratory and which should be managed in radically different ways. © 1990.